In a filing, Abeona Therapeutics Inc revealed its Chief Executive Officer Seshadri Vishwas unloaded Company’s shares for reported $0.13 million on Dec 29 ’25. In the deal valued at $5.31 per share,25,000 shares were sold. As a result of this transaction, Seshadri Vishwas now holds 1,164,818 shares worth roughly $6.03 million.
Then, Seshadri Vishwas bought 25,000 shares, generating $132,695 in total proceeds.
Before that, Alvino Mark sold 15,000 shares. Abeona Therapeutics Inc shares valued at $71,168 were divested by the Director at a price of $4.74 per share. As a result of the transaction, Alvino Mark now holds 62,252 shares, worth roughly $0.32 million.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early March with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering ABEO with “Buy” recommendation on July 03, 2024. Stifel started covering the stock on May 30, 2024. It rated ABEO as “a Buy”.
Price Performance Review of ABEO
On Tuesday, Abeona Therapeutics Inc [NASDAQ:ABEO] saw its stock fall -3.54% to $5.18. Over the last five days, the stock has lost -4.78%. Abeona Therapeutics Inc shares have fallen nearly -9.44% since the year began. Nevertheless, the stocks have fallen -7.00% over the past one year. While a 52-week high of $7.54 was reached on 08/15/25, a 52-week low of $3.93 was recorded on 04/09/25.
Levels Of Support And Resistance For ABEO Stock
The 24-hour chart illustrates a support level at 5.09, which if violated will result in even more drops to 4.99. On the upside, there is a resistance level at 5.35. A further resistance level may holdings at 5.51.
How much short interest is there in Abeona Therapeutics Inc?
A steep rise in short interest was recorded in Abeona Therapeutics Inc stocks on 2025-12-15, growing by 0.41 million shares to a total of 14.0 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 13.59 million shares. There was a rise of 2.92%, which implies that there is a positive sentiment for the stock.
